The therapies that show promising results in reducing neuroinflammation and cognitive decline include SGLT2 inhibitors, TNF-α inhibitors, and natural anti-inflammatory substances.TNF-α Inhibitors: The TNF-α inhibitor etanercept has shown surprisingly major cognitive improvements in small-scale studies done on AD patients. This evidence concerns the gene TNF and Alzheimer disease.